netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Glucose found 36 matches

Formulary items 16 matches
Sub Section Title / notes 8  matches
   
Open monograph to display formulary status BNF Category
  Glucose Nutrition and blood - Intravenous glucose - 09.02.02.01
  Glucose 5%, 10%, 25% & 50%
(Injection)
Endocrine system - Treatment of hypoglycaemia - 06.01.04
  Glucose 40% Oral Gel  (GlucoGel®) Endocrine system - Treatment of hypoglycaemia - 06.01.04
  Plasma-lyte 148 with Glucose 5% Nutrition and blood - Plasma and plasma substitutes - 09.02.02.02
  Sodium Chloride and Glucose Nutrition and blood - Intravenous sodium - 09.02.02.01
  Bupivacaine Hydrochloride Anaesthesia - Bupivacaine - 15.02
  Doxapram Anaesthesia - Antagonists for central and respiratory depression - 15.01.07
  Finerenone  (Kerendia®) Cardiovascular system - Potassium-sparing diuretics and aldosterone antagonists - 02.02.03
  Flaminal ® Hydro Gel Wound Care - Other antimicrobials - 18.03.04
  Flaminal® Forte Gel Wound Care - Other antimicrobials - 18.03.04
  Freestyle Libre 2 Plus® Endocrine system - Blood glucose monitoring - 06.01.06
  Freestyle Libre 2® Endocrine system - Blood glucose monitoring - 06.01.06
  Freestyle Libre 3® Endocrine system - Blood glucose monitoring - 06.01.06
  Premixed potassium infusion bags Nutrition and blood - Intravenous potassium - 09.02.02.01
  Steriflex 165® Nutrition and blood - Parenteral preparations for fluid and electrolyte imbalance - 09.02.02
  Vitamin B & C injection  (Pabrinex®) Nutrition and blood - Vitamin B group - 09.06.02
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in subsection MHRA Drug Safety Update (October 2024): Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme (06.01.06)
link in drug section MHRA: Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions instead of saline solutions in arterial lines (May 2023) (09.02.02.01)
link in subsection NENC Guideline For Use Of Sodium Glucose Co-transporter 2 Inhibitors (SGLT2i) in Adults (06.01.02.03)
link in subsection NHSE Commissioning recommendations following the national assessment of blood glucose and ketone meters, testing strips and lancets (06.01.06)
link in subsection North East and North Cumbria ICB - Guidelines: Self-Monitoring of Blood Glucose and Ketones in Diabetes (06.01.06)
link in subsection North East Guideline For Use Of Sodium Glucose Co transporter 2 Inhibitors (SGLT2i) (02.15)
link in drug section NTAG Continuous Glucose Monitoring (CGM) System Position Statement (May 2024) (06.01.06)
link in drug section NTAG Continuous Glucose Monitoring (CGM) System Position Statement (May 2024) (06.01.06)
link in drug section NTAG Continuous Glucose Monitoring (CGM) System Position Statement (May 2024) (06.01.06)
link in drug section NTAG Continuous Glucose Monitoring (CGM) System Position Statement (May 2024) (06.01.06)
link in drug section NTAG Continuous Glucose Monitoring (CGM) System Position Statement (May 2024) (06.01.06)
link in subsection NTAG Continuous Glucose Monitoring (CGM) System Position Statement (May 2024) (06.01.06)

SubSection Titles / notes  
Blood Glucose meters for adults with type 2 diabetes - (06.01.06)
Blood Glucose meters for children and adults with type 1 diabetes - (06.01.06)
Blood Glucose meters for patients on continuous insulin infusion pump - (06.01.06)
Blood Glucose meters for patients with dexterity problems - (06.01.06)
Blood Glucose monitoring - (06.01.06)
Intravenous Glucose - (09.02.02.01)
Oral Glucose tolerance test - (06.01.06)
Talking blood Glucose meters - (06.01.06)

 

netFormulary